Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Artivion, Inc. stock logo
AORT
Artivion
$30.30
+2.0%
$27.21
$21.97
$32.33
$1.27B1.62338,729 shs549,608 shs
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$32.90
-2.5%
$32.87
$27.07
$40.28
$1.37B1.36258,987 shs579,876 shs
Outset Medical, Inc. stock logo
OM
Outset Medical
$18.98
-3.0%
$16.15
$5.85
$72.60
$346.83M2.15128,118 shs1.42 million shs
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$20.22
-0.9%
$20.25
$15.75
$48.24
$1.36B1.521.50 million shs1.12 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Artivion, Inc. stock logo
AORT
Artivion
+2.14%+7.40%+6.14%+23.82%+30.65%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
-2.63%-4.54%-1.66%+5.36%+1.66%
Outset Medical, Inc. stock logo
OM
Outset Medical
-3.01%-4.91%+2.04%+88.86%-65.24%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-0.93%-2.60%-6.61%-0.34%-52.79%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Artivion, Inc. stock logo
AORT
Artivion
2.5659 of 5 stars
1.65.00.00.02.42.51.9
Cadre Holdings, Inc. stock logo
CDRE
Cadre
3.1324 of 5 stars
2.33.02.50.01.23.31.9
Outset Medical, Inc. stock logo
OM
Outset Medical
1.3818 of 5 stars
3.53.00.00.00.00.80.0
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
4.1311 of 5 stars
4.21.00.04.93.00.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Artivion, Inc. stock logo
AORT
Artivion
3.14
Buy$32.005.62% Upside
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.50
Moderate Buy$37.5013.99% Upside
Outset Medical, Inc. stock logo
OM
Outset Medical
3.00
Buy$27.0042.26% Upside
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2.40
Hold$33.4365.32% Upside

Current Analyst Ratings Breakdown

Latest OM, CDRE, TNDM, and AORT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/17/2025
Artivion, Inc. stock logo
AORT
Artivion
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$35.00
6/16/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$24.00
6/13/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$45.00 ➝ $38.00
5/22/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$20.00 ➝ $24.00
5/21/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Perform ➝ Sector Perform$14.00 ➝ $21.00
5/15/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/8/2025
Outset Medical, Inc. stock logo
OM
Outset Medical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$12.00 ➝ $14.00
5/6/2025
Artivion, Inc. stock logo
AORT
Artivion
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
5/6/2025
Artivion, Inc. stock logo
AORT
Artivion
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$33.00 ➝ $33.00
5/6/2025
Artivion, Inc. stock logo
AORT
Artivion
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$32.00 ➝ $32.00
5/1/2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$58.00 ➝ $59.00
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Artivion, Inc. stock logo
AORT
Artivion
$388.54M3.33$0.85 per share35.60$6.59 per share4.60
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$567.56M2.36$1.38 per share23.81$7.67 per share4.29
Outset Medical, Inc. stock logo
OM
Outset Medical
$113.69M2.96N/AN/A$7.49 per share2.53
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
$940.20M1.43N/AN/A$4.01 per share5.04
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Artivion, Inc. stock logo
AORT
Artivion
-$13.36M-$0.50N/A60.60N/A-5.49%3.63%1.34%8/6/2025 (Estimated)
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$36.13M$0.9534.6324.191.246.87%12.52%6.04%8/8/2025 (Estimated)
Outset Medical, Inc. stock logo
OM
Outset Medical
-$127.98M-$29.15N/AN/A-98.74%-143.62%-37.50%8/6/2025 (Estimated)
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$96.03M-$2.78N/AN/AN/A-18.71%-57.33%-13.48%7/30/2025 (Estimated)

Latest OM, CDRE, TNDM, and AORT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
Outset Medical, Inc. stock logo
OM
Outset Medical
-$0.97-$3.66-$2.69-$3.66$27.81 million$29.75 million
5/6/2025Q1 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.13$0.23+$0.10$0.23$121.53 million$130.11 million
5/5/2025Q1 2025
Artivion, Inc. stock logo
AORT
Artivion
$0.12$0.06-$0.06-$0.01$94.81 million$98.98 million
4/30/2025Q1 2025
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
-$0.60-$0.67-$0.07-$1.97$220.19 million$234.42 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Artivion, Inc. stock logo
AORT
Artivion
N/AN/AN/AN/AN/A
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.381.16%N/A40.00%2 Years
Outset Medical, Inc. stock logo
OM
Outset Medical
N/AN/AN/AN/AN/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/AN/AN/AN/AN/A

Latest OM, CDRE, TNDM, and AORT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.29%5/2/20255/2/20255/16/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Artivion, Inc. stock logo
AORT
Artivion
1.08
5.53
3.95
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.66
3.55
2.57
Outset Medical, Inc. stock logo
OM
Outset Medical
0.57
8.37
6.74
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.99
2.30
1.81

Institutional Ownership

CompanyInstitutional Ownership
Artivion, Inc. stock logo
AORT
Artivion
86.37%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
Outset Medical, Inc. stock logo
OM
Outset Medical
N/A
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
N/A

Insider Ownership

CompanyInsider Ownership
Artivion, Inc. stock logo
AORT
Artivion
7.60%
Cadre Holdings, Inc. stock logo
CDRE
Cadre
37.00%
Outset Medical, Inc. stock logo
OM
Outset Medical
2.40%
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
1.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Artivion, Inc. stock logo
AORT
Artivion
1,60042.70 million39.46 millionOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,28440.66 million25.62 millionOptionable
Outset Medical, Inc. stock logo
OM
Outset Medical
52017.72 million17.30 millionNot Optionable
Tandem Diabetes Care, Inc. stock logo
TNDM
Tandem Diabetes Care
2,65066.61 million65.34 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Artivion stock logo

Artivion NYSE:AORT

$30.30 +0.60 (+2.01%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$30.27 -0.03 (-0.09%)
As of 06/20/2025 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Cadre stock logo

Cadre NYSE:CDRE

$32.90 -0.83 (-2.47%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$32.87 -0.03 (-0.08%)
As of 06/20/2025 04:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

Outset Medical stock logo

Outset Medical NASDAQ:OM

$18.98 -0.59 (-3.01%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$18.99 +0.01 (+0.05%)
As of 06/20/2025 04:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Tandem Diabetes Care stock logo

Tandem Diabetes Care NASDAQ:TNDM

$20.22 -0.19 (-0.93%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$20.38 +0.16 (+0.79%)
As of 06/20/2025 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.